Ropsacitinib
Ropsacitinib is a drug which is an orally active, selective tyrosine kinase 2 inhibitor. It has been researched for various autoimmune inflammatory conditions, primarily plaque psoriasis.
Ropsacitinib is a drug which is an orally active, selective tyrosine kinase 2 inhibitor. It has been researched for various autoimmune inflammatory conditions, primarily plaque psoriasis.